390 related articles for article (PubMed ID: 27904525)
1. Exosomes as nanocarriers for siRNA delivery: paradigms and challenges.
Shahabipour F; Banach M; Sahebkar A
Arch Med Sci; 2016 Dec; 12(6):1324-1326. PubMed ID: 27904525
[TBL] [Abstract][Full Text] [Related]
2. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
[TBL] [Abstract][Full Text] [Related]
3. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
[TBL] [Abstract][Full Text] [Related]
4. Exosome as a Natural Gene Delivery Vector for Cancer Treatment.
Pofali P; Mondal A; Londhe V
Curr Cancer Drug Targets; 2020; 20(11):821-830. PubMed ID: 32972340
[TBL] [Abstract][Full Text] [Related]
5. Comparison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA.
Lu M; Zhao X; Xing H; Xun Z; Zhu S; Lang L; Yang T; Cai C; Wang D; Ding P
Int J Pharm; 2018 Oct; 550(1-2):100-113. PubMed ID: 30138707
[TBL] [Abstract][Full Text] [Related]
6. Development and regulation of exosome-based therapy products.
Batrakova EV; Kim MS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):744-57. PubMed ID: 26888041
[TBL] [Abstract][Full Text] [Related]
7. Artificial exosomes for translational nanomedicine.
Li YJ; Wu JY; Liu J; Xu W; Qiu X; Huang S; Hu XB; Xiang DX
J Nanobiotechnology; 2021 Aug; 19(1):242. PubMed ID: 34384440
[TBL] [Abstract][Full Text] [Related]
8. Virus-modified exosomes for targeted RNA delivery; a new approach in nanomedicine.
Koppers-Lalic D; Hogenboom MM; Middeldorp JM; Pegtel DM
Adv Drug Deliv Rev; 2013 Mar; 65(3):348-56. PubMed ID: 22820525
[TBL] [Abstract][Full Text] [Related]
9. Engineering exosomes as refined biological nanoplatforms for drug delivery.
Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
[TBL] [Abstract][Full Text] [Related]
10. Tumor-targeted exosomes for delivery of anticancer drugs.
Raguraman R; Bhavsar D; Kim D; Ren X; Sikavitsas V; Munshi A; Ramesh R
Cancer Lett; 2023 Apr; 558():216093. PubMed ID: 36822543
[TBL] [Abstract][Full Text] [Related]
11. FedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly Deliver.
Marcus ME; Leonard JN
Pharmaceuticals (Basel); 2013; 6(5):659-80. PubMed ID: 23894228
[TBL] [Abstract][Full Text] [Related]
12. Post isolation modification of exosomes for nanomedicine applications.
Hood JL
Nanomedicine (Lond); 2016 Jul; 11(13):1745-56. PubMed ID: 27348448
[TBL] [Abstract][Full Text] [Related]
13. Exosomes as Drug Delivery Systems: Endogenous Nanovehicles for Treatment of Systemic Lupus Erythematosus.
Ortega A; Martinez-Arroyo O; Forner MJ; Cortes R
Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33374908
[TBL] [Abstract][Full Text] [Related]
14. [Exosome-Mediated Small RNA Delivery For Gene Therapy].
Sun W; Cao FJ; Wang N; Zhou Y; Ba Y; Zhang CY
Sheng Li Ke Xue Jin Zhan; 2016 Jun; 47(3):162-7. PubMed ID: 29888878
[TBL] [Abstract][Full Text] [Related]
15. Exosomes: Therapy delivery tools and biomarkers of diseases.
Barile L; Vassalli G
Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
[TBL] [Abstract][Full Text] [Related]
16. Exosome: From biology to drug delivery.
Baruah H; Sarma A; Basak D; Das M
Drug Deliv Transl Res; 2024 Jun; 14(6):1480-1516. PubMed ID: 38252268
[TBL] [Abstract][Full Text] [Related]
17. Exosome-based nanomedicine for cancer treatment by targeting inflammatory pathways: Current status and future perspectives.
Ansari MA; Thiruvengadam M; Venkidasamy B; Alomary MN; Salawi A; Chung IM; Shariati MA; Rebezov M
Semin Cancer Biol; 2022 Nov; 86(Pt 2):678-696. PubMed ID: 35452820
[TBL] [Abstract][Full Text] [Related]
18. Exosome-Based Delivery of Natural Products in Cancer Therapy.
Song H; Liu B; Dong B; Xu J; Zhou H; Na S; Liu Y; Pan Y; Chen F; Li L; Wang J
Front Cell Dev Biol; 2021; 9():650426. PubMed ID: 33738290
[TBL] [Abstract][Full Text] [Related]
19. Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers.
Lakhal S; Wood MJ
Bioessays; 2011 Oct; 33(10):737-41. PubMed ID: 21932222
[TBL] [Abstract][Full Text] [Related]
20. Current Knowledge and Future Perspectives of Exosomes as Nanocarriers in Diagnosis and Treatment of Diseases.
Zou Z; Li H; Xu G; Hu Y; Zhang W; Tian K
Int J Nanomedicine; 2023; 18():4751-4778. PubMed ID: 37635911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
